جست‌وجوی استاد و پژوهشگر

Mark S Moehleمشاهده پروفایل

استادیار

• Neurological Disorders
• Movement Disorders
• Parkinson’s Disease
• +۵ مورد دیگر

Mark S Moehle is an Assistant Professor in the Department of Pharmacology and Therapeutics at the University of Florida. His research focuses on understanding cellular and molecular mechanisms underlying neurological disorders such as Parkinson’s disease, dystonia, and Lewy Body Dementia. He leads the Moehle Laboratory, which employs pharmacological, electrophysiological, and behavioral techniques to investigate therapeutic strategies targeting muscarinic acetylcholine receptors (M4) and LRRK2 pathways. Moehle holds a PhD from Vanderbilt University and completed postdoctoral training at the University of Florida. He teaches courses including Pharmacotherapeutics I, Principles of Pharmacology, and Neuroscience seminars. Active grants include studies on α-synuclein pathology, cholinergic mechanisms in Lewy Body Dementia, and M4 receptor modulation in Parkinson’s disease. His work bridges basic science and translational research, aiming to develop novel treatments for movement disorders. Education: PhD in Pharmacology (2015), Vanderbilt University Postdoctoral Fellowship (2015–2020), University of Florida Bachelor of Science (2010), Centenary College of Louisiana Research Interests: Molecular mechanisms of α-synuclein aggregation and neurodegeneration Role of M4 muscarinic receptors in movement disorder pathogenesis Genetic and pharmacological modulation of LRRK2 signaling Development of antiparkinsonian and antidystonic therapies Grants & Funding: Principal Investigator: NIH NINDS (Lewy Body Dementia research) Michael J. Fox Foundation (M5 modulators and α-synuclein studies) Co-Investigator: DYT1 dystonia modeling Labs & Teams: Moehle Lab: Focused on circuit-level and biochemical analysis of movement disorder models Collaborations with neurology and pharmacology departments at UF

Margaret E. Riceمشاهده پروفایل

استاد

• Neurochemistry
• Neurophysiology
• Nigrostriatal dopamine pathway
• +۵ مورد دیگر

Margaret E. Rice, PhD is a Professor in both the Department of Neurosurgery and Department of Neuroscience at NYU Grossman School of Medicine. She also serves as Vice Chair of Research in the Department of Neurosurgery. Dr. Rice is an investigator in the Neuroscience Institute and a member of the Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders at NYU Langone. Her laboratory studies the neurochemistry and neurophysiology of the nigrostriatal dopamine pathway with NIH funding. Dr. Rice's research focuses on factors that regulate dopamine release, which is critical for motor and reward pathways in the brain. Current projects include examining how diet and metabolic hormones (insulin and leptin) modulate dopamine release in the striatum, investigating the influence of exercise on dopamine levels, and studying how Parkinson's-related proteins like alpha-synuclein affect dopamine neuron physiology. Her laboratory employs advanced techniques including fast-scan cyclic voltammetry, optogenetics, patch-clamp recording of basal ganglia neurons, and immunohistochemistry, primarily using ex vivo rodent brain slices. Analysis of Dr. Rice's recent publications (2016-2025) reveals a consistent focus on dopamine regulation mechanisms, particularly the interplay between metabolic factors and neurotransmission. Her work spans from molecular mechanisms of somatodendritic dopamine release to behavioral implications for understanding motivation and movement disorders. The publications demonstrate an evolution from basic dopamine release mechanisms to increasingly sophisticated investigations of metabolic-neural interactions with direct relevance to Parkinson's disease. Her 2015 Nature Communications paper demonstrated that insulin enhances striatal dopamine release by activating cholinergic interneurons, revealing insulin's role as a reward signal Her ongoing work on leptin shows it promotes dopamine release in both nigrostriatal and mesolimbic pathways through distinct mechanisms Recent studies examine how exercise increases striatal dopamine release through BDNF-dependent mechanisms Dr. Rice serves on the Scientific Advisory Board of the Parkinson's Foundation, demonstrating her standing in the field. Her research has significant implications for understanding the neural basis of motivation, reward pathways, and Parkinson's disease pathology. Dr. Rice has mentored numerous researchers including Jyoti C. Patel (Research Associate Professor), Maria Mancini (Fresco Fellow), Takuya Hikima (Instructor), and Letizia Zanetti (Visiting Fresco Scholar). Her laboratory maintains an active research program with multiple ongoing projects examining the intersection of metabolic regulation and dopamine neurotransmission, with potential applications for understanding obesity, diabetes, and neurological disorders.

Regina M. Sullivanمشاهده پروفایل

استاد

• Systems Neuroscience
• Cognitive Neuroscience
• Computational Neuroscience
• +۳ مورد دیگر

Regina M. Sullivan is a Professor in the Department of Child and Adolescent Psychiatry at the NYU Grossman School of Medicine, New York University. Her research focuses on systems, cognitive, and computational neuroscience, particularly in developmental processes and their neural underpinnings. She holds a PhD from the CUNY Graduate Center. Her work spans topics such as infant attachment learning, developmental effects of alcohol exposure, amygdala dysfunction in neurodevelopmental disorders, and neural circuits mediating maternal behavior. Notable studies include investigations into reward processing circuits and the enduring consequences of alcohol exposure during development. Dr. Sullivan’s publications highlight interdisciplinary approaches to understanding brain development, leveraging animal models to explore behavioral and neurochemical mechanisms. Her research often intersects translational psychiatry and developmental neuroscience, with implications for clinical interventions in mental health. No scientific awards are explicitly listed in the provided text. She collaborates extensively with researchers like Maya Opendak, Nim Tottenham, and Donald A. Wilson on projects funded by grants (details unspecified). Her lab’s work is featured in high-impact journals like Nature and Neuroscience & Biobehavioral Reviews .

Camilla Belloneمشاهده پروفایل

دانشیار

• Neuroscience
• Synaptic Plasticity
• Addiction Mechanisms
• +۳ مورد دیگر

Camilla Bellone is an Associate Professor in the Department of Basic Neuroscience at the University of Geneva's Faculty of Medicine. She serves as Vice-Dean for Basic Research and Technology and coordinates the Synapsy Centre for Neuroscience Research in Mental Health. Her research examines synaptic mechanisms underlying addiction and social behavior deficits in autism spectrum disorders through molecular and systems neuroscience approaches. Education includes: Master's in Pharmacy, University of Milan PhD, University of Milan Postdoctoral fellowship, University of San Francisco Dr. Bellone's research investigates synaptic plasticity in reward pathways induced by addictive substances, and neural determinants of social behavior in autism. She employs advanced techniques including optogenetics, electrophysiology, and machine learning to study neuronal circuits in the ventral tegmental area, superior colliculus, and olfactory tubercle. Current work focuses on translating findings into therapeutic strategies for neurodevelopmental disorders. Her recent publications (2022-2025) demonstrate strong focus on: neural circuitry of social behavior, autism pathophysiology, dopamine signaling, optogenetic tools, and machine learning approaches for behavioral analysis. Predominant themes include synaptic plasticity mechanisms, reward processing, threat assessment, and translational models bridging basic neuroscience with clinical applications. Scientific Awards: ERC Consolidator Grant (2019) SNSF Professorship Grant (2014) SNSF Ambizione Fellowship (2011) Dr. Bellone established her laboratory at University of Lausanne through SNSF funding before returning to Geneva. She leads research teams investigating addiction neurobiology and autism-related circuits at the Synapsy Centre. Current projects examine oxytocin's role in neuroinflammation, dopamine regulation of threat salience, and computational analysis of social behavior. As Vice-Dean, she oversees basic research initiatives and technology development within the Faculty of Medicine. Her laboratory collaborates extensively within the Synapsy Centre to advance neuroscience research in mental health disorders.

• Systems Neuroscience
• Schizophrenia
• Cannabinoids
• +۵ مورد دیگر

Judith Pratt is a Visiting Professor at the Strathclyde Institute of Pharmacy and Biomedical Sciences , University of Strathclyde. She co-directs the Psychiatric Research Institute of Neuroscience in Glasgow (PsyRING) , a collaboration between Strathclyde, Glasgow University, and NHS Greater Glasgow & Clyde. Her work focuses on molecular and neural systems underlying mental health and disease, particularly schizophrenia, cannabinoids, and translational drug discovery. Pratt holds a PhD in Neuroscience from the Institute of Psychiatry (1982). Her research identifies novel therapeutic targets (e.g., serominic) and validates mechanisms linking genetic risk factors like MAP2K7 to schizophrenia. She explores interactions between cannabis constituents (THC, cannabidiol) and environmental factors like prenatal infection and adolescent THC exposure. Key projects include a multi-center translational medicine grant with Pfizer on DISC1 mouse models and leadership in the CeNsUS (Centre for Neuroscience) at Strathclyde, advancing network science applications to brain systems and medical devices for deep brain stimulation. She engages in public science outreach, including Glasgow Science Festival and schools programs. Awards: BAP Public Communication Prize (2018). Grants: Collaborations with Pfizer, Medical Research Council (MRC), and others on translational medicine and genetic risk studies. Teams: Leads PsyRING and CeNsUS, fostering multidisciplinary collaborations in neuroscience and drug development.

Christoph Mulertمشاهده پروفایل

استاد

• Psychiatry
• Neuroscience
• Clinical Neurophysiology
• +۶ مورد دیگر

Prof. Christoph Mulert is a University Professor in Psychiatry at the University Medical Center Hamburg-Eppendorf (UKE), leading the research area in imaging and the working area for personality disorders/DBT. He holds positions as Head of the Department of Psychiatry and Psychotherapy's research and clinical divisions, including senior physician roles in personality disorder wards. His expertise spans neuropsychiatric disorders, particularly schizophrenia, bipolar disorder, and borderline personality disorder, with a focus on EEG-fMRI integration, brain oscillations, and transcranial stimulation. Research highlights include studies on glutamatergic mechanisms, functional connectivity, and neuroimaging biomarkers. His work bridges clinical psychiatry with neurophysiological insights, addressing translational challenges in mental health treatment. Education and career details are not explicitly listed, though his academic title (Dr. med.) indicates a medical doctorate. His research integrates multimodal neuroimaging techniques, emphasizing EEG and fMRI to study cognitive and emotional processes in psychiatric conditions. Key contributions include protocols for transdiagnostic therapy (e.g., TransTAM) and studies on glycine modulation in schizophrenia models. Prof. Mulert’s lab focuses on translational research, combining clinical interventions with neurophysiological assessments. Notable collaborations include the German Research Consortium BipoLife for bipolar disorder studies. He actively publishes on topics like telemedicine applications, psychedelic research (e.g., ketamine), and neuroimaging-based risk prediction models using machine learning.

• Neuroscience
• Cognitive Mechanisms
• Prefrontal Cortex Function
• +۳ مورد دیگر

Marie Carlen is a Professor of Neuronal Networks at the Department of Neuroscience, Karolinska Institutet. Her research focuses on the cellular and circuit mechanisms underlying cognition, particularly in the prefrontal cortex. She completed her Ph.D. in medicine at Karolinska Institutet in 2005, followed by postdoctoral studies at MIT with Li-Huei Tsai. Her lab uses optogenetics, calcium imaging, and high-density electrophysiology to study cognitive processing in rodents, aiming to map functional features of the prefrontal cortex across species. Carlen has received numerous awards, including the Wallenberg Scholar and ERC Starting Grant. She leads the 'Neural circuits of cognition' group and collaborates with institutions globally. Her work bridges basic neuroscience with translational research, addressing mental disorders linked to prefrontal dysfunction.

Gilberto Fisoneمشاهده پروفایل

استاد

• Neurosciences
• Pharmacology and Toxicology
• Parkinson's Disease
• +۳ مورد دیگر

Gilberto Fisone is a Professor and Head of the Department of Neuroscience at Karolinska Institutet. His research focuses on understanding the molecular and cellular mechanisms underlying neurodegenerative and neuropsychiatric disorders, particularly Parkinson’s disease (PD), with an emphasis on motor and non-motor symptoms and complications of dopamine replacement therapies. He holds academic positions including Professor of Neuroscience (2006–present) and Head of Department (2021–present). Education: BSc from the University of Pavia (1982), Ph.D. from Stockholm University (1990), followed by postdoctoral training at The Rockefeller University (1991–1995). His career includes roles as Assistant and Associate Professor at Karolinska Institutet before becoming a Full Professor in 2006. Research interests include: Mechanisms of L-DOPA-induced dyskinesia and psychiatric complications (e.g., addiction-like behaviors). Non-motor symptoms in PD, such as sleep disorders, anxiety, and circadian rhythm disruptions. Role of signal transduction pathways (cAMP, ERK, mTOR) in PD pathology. Notable contributions include developing mouse models to study PD comorbidities and identifying autophagy as a therapeutic target for dyskinesia. His work has been supported by grants, including the Neurophage project exploring non-invasive neural stimulation. Awards and roles: Member of Academia Europaea (2022–present), Secretary of the International Basal Ganglia Society, and leadership in international collaborations. His lab, 'Molecular and Circuit Neuropharmacology', investigates neural circuits and pharmacological interventions in neurodegenerative diseases.

• Neurobiology
• Parkinson's Disease
• Mitochondrial Genetics
• +۲ مورد دیگر

Lars Olson is a Senior Professor in Neurobiology at Karolinska Institutet's Department of Neuroscience. His research explores neurobiology, Parkinson's disease mechanisms, mitochondrial genetics in aging, and neural repair after spinal cord injury. He co-leads Tobias Karlsson's research group and founded the Swedish Brain Foundation. Research interests include: Mitochondrial dysfunction in neurodegeneration Neural signaling pathways in Parkinson's Bioengineering for spinal cord injury recovery Publications demonstrate expertise in genetic models and neurochemical analysis, with recent work on dopamine dynamics and neuroimmune interactions. Awards include the Karolinska Institutet Grand Silver Medal (2020) for lifetime contributions to neuroscience education and research. Advising includes PhD supervision in neurobiology labs. Grants support studies on neuroregeneration and mitochondrial biology. Future work targets neural interfaces for therapeutic applications. Teams collaborate internationally on neural circuit mapping and neuroinflammation projects.

Tilo Kunathمشاهده پروفایل

دانشیار

• Neurobiology
• Stem Cell Research
• Gene Editing
• +۳ مورد دیگر

Dr. Tilo Kunath is a Reader in Regenerative Neurobiology at the University of Edinburgh's School of Biological Sciences and Co-Director of the Centre for Regenerative Medicine. His work focuses on Parkinson's disease mechanisms and cell-based therapies, particularly using CRISPR-edited stem cells to generate disease-resistant dopaminergic neurons. He leads a lab investigating α-synuclein's role in neurodegeneration and collaborates with institutions like the UK Centre for Mammalian Synthetic Biology. His research aims to translate findings into clinical therapies, with recent advancements in gene-edited cell therapies showing promise for young-onset Parkinson's patients. Education: PhD from the University of Toronto (with Prof. Janet Rossant), postdoctoral studies at Edinburgh under Prof. Austin Smith, and visiting professorship at the University of Tsukuba. He mentors PhD students and researchers, including well-supported fellows like Ammar Natalwala (Wellcome Trust). Funded by grants from Parkinson's UK, BBSRC, and industry partners like UCB. Research Interests: Mechanisms of α-synuclein-driven neurodegeneration, stem cell engineering for dopamine neuron production, CRISPR-based therapeutic strategies, and biomarker discovery for Parkinson's. Key breakthroughs include developing synucleinopathy-resistant neurons and demonstrating transplantation efficacy in animal models. Collaborations span physics, chemistry, and engineering, including partnerships with Prof. Cait MacPhee (University of Edinburgh) and Dr. Michele Zagnoni (University of Strathclyde). His work bridges basic science with translational medicine, emphasizing clinical trial readiness for cell-based therapies.

Daria Peleg-Raibsteinمشاهده پروفایل

مدرس

• Cognitive Neuroscience
• Behavioral Psychology
• Nutritional Neuroscience
• +۳ مورد دیگر

Dr. Daria Peleg-Raibstein is a Lecturer at ETH Zürich's Department of Health Sciences and Technology, affiliated with the Institut für Neurowissenschaften (Institute for Neuroscience). Her research focuses on how environmental and nutritional inputs, particularly maternal overnutrition, influence cognitive and behavioral outcomes across generations. Her independent research group has been continuously funded since 2012, investigating topics such as intergenerational effects of diet on reward systems, stress-linked cognition, and hypothalamic regulation of memory processes. Research Interests: Peleg-Raibstein’s work bridges nutritional science, neuroscience, and psychology. Key areas include the neurobiological consequences of maternal dietary choices, the role of hypothalamic circuits (e.g., orexin and MCH neurons) in memory and metabolic control, and the interplay between environmental inputs and long-term cognitive health. Her lab explores how nutritional exposures during critical developmental periods reprogram brain function, leading to risks of addiction, metabolic disorders, and cognitive decline. Recent Publications: Her 2025 review in Neuropharmacology explores hypothalamic control of memory phases and types, while her 2025 Nutrients paper highlights how maternal overnutrition impairs spatial memory in offspring. Ongoing projects include NIH-funded studies on reward systems and ETH-funded work on stress resilience mechanisms. Grants & Funding: Current grants include SNF support for reward system research and ETH funding for nutritional programming of Alzheimer’s risk. Her group maintains 1-2 postdocs and 1-3 PhD students, emphasizing translational neuroscience. Labs/Teams: Leads an independent research group at ETH Zürich, focusing on nutritional neuroscience and neuroendocrine signaling. Collaborates with institutions like the Burdakov Lab on orexin neuron studies.

Caroline Lea-Carnallمشاهده پروفایل

مدرس

• Neuroscience
• Neuroimaging (MRI/MRS)
• Neurotransmitter Dynamics
• +۳ مورد دیگر

Dr. Caroline Lea-Carnall is a Lecturer in Biological Sciences within the Division of Psychology Communication and Human Neuroscience at The University of Manchester. Her research focuses on neuroimaging techniques (e.g., MRI/MRS), neurotransmitter dynamics, and neurological disorders such as Neurofibromatosis Type 1. She holds memberships in key organizations including the Organisation for Human Brain Mapping and the International Society for Magnetic Resonance in Medicine. Education: PhD in Neuroscience from University of Manchester (2017): 'Investigating properties of functional brain networks using the resonance phenomena' MSc in Computational Neuroscience and Neuroinformatics (Distinction), University of Manchester BSc Mathematics (1st Class Honours), University of Leeds Research Interests: Her work explores synaptic plasticity mechanisms, neuroimaging methodology improvements, and the application of computational models to understand brain network dynamics. She investigates how neurotransmitters like glutamate and GABA influence brain function and recovery post-injury. Key themes include: Cortical neurotransmitter quantification via MRS Frequency-dependent neural entrainment and stimulation Cognitive and structural correlates of mental health disorders Neurological disorders such as Neurofibromatosis Type 1 and brachial plexus injuries Research Trends: Recent publications highlight advancements in MRS methodology, neuroplasticity mechanisms in disease states, and translational research linking brain structure/function to socioeconomic/mental health outcomes. She frequently collaborates on interdisciplinary projects involving computational modeling and clinical neuroimaging. Labs/Teams: Active contributor to the Division of Psychology Communication and Human Neuroscience, leading projects on brain network dynamics and neuroimaging validation. Co-developed datasets like 'Frequency-dependent cortical plasticity: evidence from psychophysics, functional imaging and computational modelling' (2017).

Benedikt Zottمشاهده پروفایل

پژوهشگر

• Neuroscience
• Alzheimer’s Disease
• Neurovascular Coupling
• +۳ مورد دیگر

Benedikt Zott is a clinician scientist at the Department of Neuroradiology and Institute of Neuroscience at Technical University of Munich (TUM). He holds an MD from TUM (2016) and a PhD in neuroscience (2019). As an Albrecht Struppler Clinician Scientist Fellow, he combines clinical radiology training with research focused on Alzheimer’s disease mechanisms and neurovascular coupling. His work identifies β-amyloid-driven neuronal hyperactivity as a critical early pathogenic event and explores therapeutic interventions targeting this pathway. Research Interests: - Alzheimer’s pathophysiology and circuit dysfunction - Neurovascular coupling mechanisms measured via fMRI - β-Amyloid accumulation and synaptic activity dysregulation - Translational approaches to neurodegenerative disease therapy Awards: 2021 Trainee Professional Development Award from the Society for Neuroscience Advising/Grants: - Supported by the TUM-IAS Albrecht Struppler Fellowship (2021–present) - Collaborates with interdisciplinary teams in neuroimaging and neuropharmacology Labs/Teams: - Member of the Focus Group 'Neuroglial circuits in health and disease' - Affiliated with the Institute for Advanced Study (TUM-IAS)

Arthur Arnoldمشاهده پروفایل

استاد پژوهشی

• Sexual Differentiation
• Sex Chromosome Biology
• Epigenetics
• +۳ مورد دیگر

Arthur Arnold is a Distinguished Research Professor in the Department of Integrative Biology and Physiology at the University of California, Los Angeles, and a member of the Brain Research Institute. His research program examines fundamental mechanisms of sexual differentiation, focusing on how sex chromosomes (X/Y) and gonadal hormones contribute to sex differences in physiology, behavior, and disease susceptibility across multiple organ systems. Dr. Arnold's laboratory investigates: Differential expression of X and Y genes in male and female cells Interactions between genetic and hormonal factors in tissue development Evolutionary biology of dosage compensation in avian species Sex-specific mechanisms in cardiovascular, neural, and immune function His work utilizes innovative mouse models including the Four Core Genotypes model to disentangle chromosomal and hormonal effects. Analysis of Dr. Arnold's recent publications (2023-2025) reveals consistent investigation of sex differences in: Cardiovascular and pulmonary pathophysiology Neurodegenerative disease mechanisms Epigenetic regulation of immune function Development of preclinical research frameworks Chromosomal contributions to metabolic disorders This body of work demonstrates his leadership in establishing biological sex as a critical variable in disease research.

• Deep Brain Stimulation
• Neuromodulation
• Chronic Pain
• +۳ مورد دیگر

Ausaf Bari is an Associate Professor in both Neurosurgery and Radiation Oncology at the David Geffen School of Medicine at UCLA. His work bridges the fields of neurosurgery, neuroscience, and neuromodulation, with a particular focus on developing innovative treatments for neurological and psychiatric disorders through deep brain stimulation and related technologies. Dr. Bari's research primarily focuses on deep brain stimulation (DBS) and neuromodulation therapies for various conditions including chronic pain, essential tremor, Parkinson's disease, epilepsy, and psychiatric disorders. His work spans both clinical applications and fundamental neuroscience research, examining how brain circuitry relates to neurological function and dysfunction. His research integrates advanced neuroimaging techniques, electrophysiological recordings, and computational approaches to improve neuromodulation therapies. Dr. Bari's publication record demonstrates a strong focus on improving targeting precision for deep brain stimulation procedures, understanding the neural mechanisms underlying pain perception and modulation, and expanding the applications of neuromodulation to new conditions. His recent work has particularly emphasized chronic pain treatment through subgenual cingulate cortex stimulation, as well as refining thalamic targets for movement disorders and epilepsy. Deep Brain Stimulation Targeting: Research on precise anatomical targeting for DBS procedures using advanced imaging and tractography Chronic Pain Mechanisms: Investigation of thalamic and cortical circuits involved in chronic pain perception Neuromodulation for Psychiatric Disorders: Exploration of DBS applications for treatment-resistant depression and other psychiatric conditions Advanced Neuroimaging: Development of connectivity-based approaches to understand brain circuitry relevant to neuromodulation Dr. Bari has received research funding from the NIH, including the grant "Deep Brain Stimulation of the Subgenual Cingulate Cortex for the Treatment of Medically Refractory Chronic Low Back Pain" (NIH UH3NS113661, 2019-2024), where he serves as Principal Investigator. This work represents a pioneering effort to apply neuromodulation techniques to chronic pain conditions that have been traditionally difficult to treat.